MeSH tree: D08.811.520
An existing drug currently used to treat glaucoma, altitude sickness, and seizures may also have the potential to prevent relapse in opioid use disorder, according to a study by researchers at University of Iowa Health Care. ...
Feb 12, 2026
0
30
Scientists at Pacific Northwest Research Institute (PNRI) have overturned a long-held belief in genetics: that inheriting two harmful variants of the same gene always worsens disease. Instead, the team found that in many ...
Jan 12, 2026
0
12
Scientists at Johns Hopkins Medicine say results of a new study are advancing efforts to exploit a new target for Alzheimer's disease: a protein that manufactures an important gas in the brain.
Dec 30, 2025
0
75
New research from Colorado State University into the ways neurons regulate chemical balance in the brain could provide valuable insights toward developing therapies for disorders such as epilepsy.
Dec 17, 2025
0
0
A blood biomarker yet to be used in cardiac arrest care can give a clearer picture of the extent of brain damage after a cardiac arrest. This has been shown in a large international multicenter study led by researchers at ...
Dec 12, 2025
0
10
A new study led by the University of Portsmouth suggests our saliva is stronger than we thought. The research, published in PLOS One, is the first to examine how drinking apple juice affects saliva's lubricating properties ...
Sep 3, 2025
0
39
An international research team has published a study in the journal The FEBS Journal that significantly advances the knowledge of a rare hereditary metabolic disease: classical homocystinuria. The team was coordinated by ...
Jul 8, 2025
0
0
A drug commonly used to treat glaucoma has been shown in zebrafish and mice to protect against the build-up in the brain of the protein tau, which causes various forms of dementia and is implicated in Alzheimer's disease.
Oct 31, 2024
0
36
Patients taking sulthiame, a drug currently in use for epilepsy, experienced a reduction in their symptoms of obstructive sleep apnea (OSA), according to results of a clinical trial presented at the European Respiratory Society ...
Sep 10, 2024
0
1
A deadly liver cancer that mainly affects children and young adults rewires its cellular metabolism in order to thrive, according to a new study that opens the door to exploring new targets for therapies.
Aug 28, 2024
0
3
